CrewCrew
FeedSignalsMy Subscriptions
Get Started
Venture Capital Pulse

Venture Capital Pulse — 2026-06-22

  1. Signals
  2. /
  3. Venture Capital Pulse

Venture Capital Pulse — 2026-06-22

Venture Capital Pulse|June 22, 20263 min read9.1AI quality score — automatically evaluated based on accuracy, depth, and source quality
0 subscribers

This week saw a slower pace of mega-rounds compared to recent weeks, with world-model AI startup Odyssey leading at $310M in a mixed funding environment. Biotech continues to attract large capital, while U.S. AI dominance persists, capturing nearly 80% of global seed-to-growth stage financing. The venture market shows signs of consolidation around larger, proven companies rather than broad-based fundraising activity.

Venture Capital Pulse — 2026-06-22

Top 10 funding rounds chart
Top 10 funding rounds chart

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

The $100M+ Round Is Now Just Your Typical Late-Stage Financing

news.crunchbase.com

Billion-Dollar AI Rounds Push April To Third-Highest Startup Funding Month In A Year

news.crunchbase.com

The Week’s 10 Biggest Funding Rounds: World-Model Startup Odyssey Leads With $310M In Slower Week Fo


Top Deals This Week


Odyssey — $310 million Series Round

  • Sector: Artificial Intelligence (world models)
  • Lead investor(s): Not disclosed
  • What they do: AI platform building world models for autonomous systems and simulation
  • Why it matters: World-model AI represents a frontier in AI development, moving beyond large language models into spatial reasoning and physics simulation—critical for robotics and autonomous vehicles

Memento Biotherapeutics — $93 million Series Round

  • Sector: Biotechnology
  • Lead investor(s): Not disclosed
  • What they do: Biopharmaceutical company focused on immunotherapy
  • Why it matters: Signals continued investor appetite for late-stage biotech despite broader market caution; $50M+ biotech rounds remain robust

Triveni Biologics — $65 million Series Round

  • Sector: Biotechnology
  • Lead investor(s): Not disclosed
  • What they do: Biologics-focused biopharmaceutical platform
  • Why it matters: Back-to-back $50M+ biotech rounds indicate sector resilience and sustained LP capital deployment in life sciences

Round — €6 million Seed

  • Sector: FinTech (AI-powered finance automation)
  • Lead investor(s): Alstin Capital (lead), with participation from BACKED VC and Love Ventures
  • What they do: AI-powered finance automation platform for European fast-growing companies
  • Why it matters: European founders attracting top-tier seed capital; demonstrates geographic diversification in AI funding beyond U.S.

Sector Spotlight

U.S. AI Dominance Extends

In a significant market signal, U.S. companies have captured nearly 80% of global seed- through growth-stage AI financing so far in 2026, per Crunchbase data. This represents a sharp divergence from pre-AI-boom years when American companies typically secured less than half of all venture investment globally.

Increasing funding to AI startups
Increasing funding to AI startups

The concentration reflects several factors: (1) access to largest LPs and institutions; (2) proximity to cloud infrastructure and GPU availability; (3) talent density in Silicon Valley and other U.S. tech hubs. For international founders, the data suggests a challenging fundraising environment outside the U.S., even for AI-native companies.

This trend has profound implications: European and Asian startups may face higher bars for capital despite strong technological capability, and U.S. venture returns could face pressure if capital becomes too concentrated in a single geography.

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

news.crunchbase.com

The $100M+ Round Is Now Just Your Typical Late-Stage Financing

news.crunchbase.com

Billion-Dollar AI Rounds Push April To Third-Highest Startup Funding Month In A Year

news.crunchbase.com

The Week’s 10 Biggest Funding Rounds: World-Model Startup Odyssey Leads With $310M In Slower Week Fo


Exits & Acquisitions

SpaceX IPO Signals "Hot IPO Summer"

SpaceX is moving toward an anticipated public offering in 2026, with sources citing it as a potential catalyst for the broader space-tech and venture ecosystem. Early VC winners include Founders Fund, Andreessen Horowitz, and Valor Capital, which backed the company early. The IPO is expected to unlock billions in returns and reinvigorate exit appetite for late-stage space tech startups still reliant on private capital.

Separately, OpenAI and Anthropic IPO filings are anticipated in the coming months, positioning 2026 as a potentially record exit year for the venture industry after two years of limited liquidity events.


What to Watch Next Week

  • SpaceX IPO roadshow expected — major IPO event could reset exit sentiment across venture-backed companies
  • Anthropic and OpenAI IPO filings — both companies may announce public offerings within 7-10 days, marking potential turning point for AI exits
  • Capital concentration trend acceleration — watch for announcements of mega-rounds ($500M+) consolidating funding to proven AI leaders
  • Secondary market activity — expect increased LP-to-LP trading as pre-IPO companies draw near public markets

Editor's Note: This week showed a notable slowdown in headline mega-rounds ($500M+) compared to recent weeks. Capital remains deployed, but increasingly selective—a sign that the venture market is entering a "quality-over-quantity" phase after the 2024–2025 AI boom. Founders without strong unit economics or differentiated technology should expect headwinds in upcoming fundraising conversations.

This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.

Explore related topics
  • QWho led the $310M Odyssey funding round?
  • QWhat impact will a SpaceX IPO have on space-tech?
  • QWhy is AI funding so concentrated in the U.S.?
  • QAre biotech valuations holding steady this year?

Powered by

CrewCrew

Sources

Want your own AI intelligence feed?

Create custom signals on any topic. AI curates and delivers 24/7.